Omnicell Inc
General ticker "OMCL" information:
- Sector: Health Care
- Industry: Health Care Equipment & Supplies
- Capitalization: $2.1B
Omnicell Inc follows the US Stock Market performance with the rate: 37.8%.
Estimated limits based on current volatility of 1.8%: low 43.68$, high 45.28$
Factors to consider:
- US accounted for 88.2% of revenue in the fiscal year ended 2023-12-31
- Price in estimated range
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [24.65$, 50.11$]
- 2024-12-30 to 2025-12-30 estimated range: [32.19$, 59.81$]
Financial Metrics affecting the OMCL estimates:
- Negative: Operating profit margin, % of -2.95 <= 1.03
- Positive: 0.93 < Non-GAAP EPS, $ of 1.91
- Negative: negative Net income
- Positive: -3.48 < Investing cash flow per share, $ of -1.22
- Negative: Industry operating cash flow per share per price (median), % of -5.15 <= 3.85
Short-term OMCL quotes
Long-term OMCL plot with estimates
Financial data
YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
---|---|---|---|
Operating Revenue | $1,132.02MM | $1,295.95MM | $1,147.11MM |
Operating Expenses | $1,042.51MM | $1,298.27MM | $1,181.98MM |
Operating Income | $89.51MM | $-2.32MM | $-34.87MM |
Non-Operating Income | $-23.50MM | $-0.13MM | $14.76MM |
Interest Expense | $23.50MM | $0.13MM | $0.00MM |
R&D Expense | $75.72MM | $104.97MM | $97.11MM |
Income(Loss) | $66.01MM | $-2.45MM | $-20.11MM |
Taxes | $-11.84MM | $-8.10MM | $0.26MM |
Profit(Loss) | $77.85MM | $5.65MM | $-20.37MM |
Stockholders Equity | $1,146.69MM | $1,130.14MM | $1,188.95MM |
Inventory | $119.92MM | $147.55MM | $110.10MM |
Assets | $2,142.50MM | $2,210.76MM | $2,226.88MM |
Operating Cash Flow | $231.81MM | $77.78MM | $181.09MM |
Capital expenditure | $58.34MM | $60.74MM | $55.02MM |
Investing Cash Flow | $-412.50MM | $-58.67MM | $-55.02MM |
Financing Cash Flow | $47.36MM | $-20.95MM | $23.42MM |
Earnings Per Share* | $1.79 | $0.13 | $-0.45 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.